Sanofi Cambridge, MA is seeking an E4A Systemic Mastocytosis/Emerging Indication HEOR Strategy Specialist to lead US-focused HEOR activities for AYVAKIT and emerging assets, shaping economic models, RWE studies, literature reviews, evidence synthesis, and payer dossiers. This role will set US evidence priorities within the HEVA team while aligning with global strategy.
You will partner with US Medical Affairs, Value & Access, and Policy teams to translate global evidence into US value
#J-18808-Ljbffr
Our organisation is growing, and we are hiring a US HEOR Lead — Systemic Mastocytosis & Emerging Indications in Quincy, MA, United States.
We invite applications for the US HEOR Lead — Systemic Mastocytosis & Emerging Indications position located in Quincy, MA, United States.
The following position is for a US HEOR Lead — Systemic Mastocytosis & Emerging Indications with Sanofi Group.